Ovarian Cancer Therapy
New ovarian cancer therapy study findings recently were published by J.R. Cubillos-Ruiz and co-researchers
Published in Women's Health Weekly, February 11th, 2010
A report, 'Blocking ovarian cancer progression by targeting tumor microenvironmental leukocytes,' is newly published data in Cell Cycle. According to recent research published in the journal Cell Cycle, "Current therapies for metastatic ovarian carcinoma are based on surgical debulking followed by chemotherapy. After more than three decades implementing treatments that selectively target the tumor cell, the 5-year survival rate for metastatic ovarian cancer patients is still lower than 30%."
"Novel strategies are therefore urgently needed to complement classical treatments for this malignancy. Recently, leukocytes in the ovarian cancer microenvironment...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Cytori Therapeutics
Cell-enriched fat grafts improve long term graft retention in preclinical study - Dana-Farber Cancer Institute
Genes found linked to breast cancer drug resistance could guide future treatment choices - Institute for Quality and Efficiency in Health Care
Women with breast cancer may benefit from autologous stem cell transplantation - Ohio State University
Yoga reduces cytokine levels known to promote inflammation - University of California - Berkeley
Study links reduced fertility to flame retardant exposure - University of California - Davis - Health System
UC Davis research confirms benefits of calcium and vitamin D in preventing fractures - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
